ENDONOVO THERAPEUTICS, INC. (ENDV) Capital expenditures 2015–2020
ENDONOVO THERAPEUTICS, INC. (ENDV) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2,594FY2020 · since FY2015: $0 → $2,594
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $2,594 | -71.1% |
| FY2019 | $8,969 | — |
| FY2016 | $3,829 | — |
| FY2015 | $0 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice